Mankind Pharma Ltd (MANKIND)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 2587.50
% Change: 0.26% (Prev Close: 2580.80)

Volume: 1,88,448
% Change: 4.42% (Prev Volume: 1,80,468)

Delivery: 1,13,669
Delivery % : 60.32
% Change: 18.94% (Prev Delivery: 95,567)

Turnover: 4,873 Lacs
% Change: 5.43% (Prev Turnover: 4,622)

πŸ’Ή EOD Valuation

P/E Ratio: 55.83
P/B Ratio: 7.45
Market Cap: 106786 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: MANKIND
Market Cap: 102002 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 3054.80
52 Week Low: 2115.10

All-Time High: 3054.80 Rs.
All-Time Low: 1240.75 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-2.28% | 8.79% | 10.49% | 6.02% | 0.00%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 72.68%

Change (3Y | 1Y): 0.00% | -0.02%

Pledged %: 0.00%

FII Holding

FII Holding: 13.07%

Change (3Y | 1Y): 0.00% | 0.15%

DII Holding

DII Holding: 11.50%

Change (3Y | 1Y): 0.00% | 0.03%

Public Holding: 2.75%

🏦 Financial Strength

Debt to Equity: 0.59
Debt: 8511.45 Rs. Cr.

Book Value: 347.39 Rs.
Current Ratio: 0.94
Interest Coverage: 5.06
Free Cash Flow: 1894.60 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 21.88%

Sales Growth Qtr (YOY | QoQ):
24.50% | 15.94%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
15.79% | 16.19% | 21.88%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: -3.46%

Profit Growth Qtr (YOY | QoQ):
-17.60% | 4.70%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
11.73% | 8.27% | -3.46%

EPS Rs.

EPS (TTM): 46.35 Rs.

EPS Qtr (Last Year | Latest):
13.39 Rs. | 10.62 Rs.

EPS Annual (Last Annual | Annual March):
47.75 Rs. | 48.26 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
11.08% | 7.21%

Net Profit Rs. Cr.

Net Profit (TTM): 1912.67 Rs. Cr.

Net Profit (Annual - March): 2011.12 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
543.07| 424.65 | 444.62

EBITDA Rs. Cr.

EBITDA (Quarter): 929.82 Rs. Cr.
EBITDA (Previous Yr Ql): 774.87 Rs. Cr.

EBITDA (Annual - March): 3247.31 Rs. Cr.
EBITDA (Previous Annual): 2676.59 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
16.49% | 15.39%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 24.73%

OPM Qtr (Previous | Current):
22.19% | 23.72%

OPM Annual (5 Yrs | Last Yr | March):
24.52% | 24.53% | 24.79%

Return on Equity %

ROE: 14.68%

ROE (5 Yrs | 3 Yrs | Last Yr):
20.20% | 17.75% | 21.53%

Return on Capital Employed %

ROCE: 15.98%

ROCE (5 Yrs | 3 Yrs | Last Yr):
26.66% | 21.52% | 26.15%

Return on Assets %

ROA (TTM): 8.89%

ROA (5 Yrs | 3 Yrs | Last Yr):
15.86% | 13.18% | 17.02%

PEG Ratio: 6.52
Dividend Yield: 0.04%

PE 3 Yrs: 49.88
PE 5 Yrs: 49.88

Dividend Yield: 0.04%

πŸ‘₯ Company

Mankind Pharma Ltd

MANKIND

Promoter Holding: %